ArticleCureus2026
Intraductal Components of Breast Cancer Spread to the Areola: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ductal spread of breast cancer sometimes causes nipple recurrence, but very rarely causes recurrence in the areola. A 65-year-old woman visited our hospital for a detailed examination of a newly developed small induration in the right areola, 15 years after undergoing nipple-preserving surgery for luminal-type breast cancer. The patient had also developed contralateral luminal-type breast cancer six years after the first operation and had undergone nipple-preserving surgery again. MRI at the second operation had shown no abnormalities in the right nipple-areolar complex (NAC). On her first visit to our hospital, we palpated a firm induration in the right areola. Ultrasound showed a mass in the areolar skin with suspected dermal disruption. Core needle biopsy showed invasive cancer cells on pathological examination. The patient, therefore, underwent resection of the NAC with adequate safety margins. Postoperative pathological study showed luminal-type invasive cancer cells mainly growing in the areolar skin with minimal fat invasion, and two solid luminal-type non-invasive ductal cancers (DCISs): one near the areolar skin and the other deeper in the subcutaneous fat tissue around the NAC. The two DCISs had small, discontinuous mammary duct structures around them with linear fibrous components, i.e., the presumed Cooper ligament. The non-malignant mammary duct structures extended toward the areola, and some of them were located closer to the areolar skin than the DCIS focus located near the skin. We, therefore, judged that this areolar recurrence was caused by DCIS that had been present in the mammary ducts extending toward the areola. Breast surgeons should note that the intraductal components of breast cancer can have ductal spread toward the areola and should resect the Cooper ligament when it is identified around the NAC during the operation to avoid this type of areolar recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.